News Blog
Achieves fourth quarter revenue growth of 3% reported and 7% organic, driven by CAG Diagnostics recurring revenue growth of 4% reported and 8% organic Solid growth supported by continued benefits…
MEXICO CITY, Feb. 3, 2023 /PRNewswire/ — Financiera Independencia, S.A.B. de C.V., Sociedad Financiera de Objeto Múltiple, Entidad No Regulada (“FINDEP” or the “Company“), is announcing today the early tender…
WHIPPANY, N.J., Feb. 2, 2023 /PRNewswire/ — Suburban Propane Partners, L.P. (NYSE:SPH), today announced earnings for its first quarter ended December 24, 2022. Net income for the first quarter of fiscal…
Continued strong performance and year-over-year revenue growth in aerospace and defense Q4 2022 sales of $1.01 billion up 32% over Q4 2021; full year 2022 sales of $3.84 billion up…
Net income attributable to SXC was $100.7 million, or $1.19 per share, for the full-year 2022; Net income attributable to SXC was $11.8 million, or $0.14 per share, in the…
ROME, Jan. 24, 2023 /PRNewswire/ — ENEL – Società per Azioni (the “Company“), today announces that, in connection with its previously announced cash tender offer (the “USD Tender Offer“) for its…
SANTO DOMINGO, Dominican Republic, Jan. 24, 2023 /PRNewswire/ — The Dominican Republic (the “Republic“) announced today the commencement of an offer to purchase for cash (the “Offer“) from each registered holder…
Treatment with futibatinib resulted in durable responses and survival surpassing historical data with chemotherapy in patients with previously treated disease. Patients in the study reported stable quality of life over…
– Mean Annualized Bleed Rate Reduced by 80% from Baseline and Factor VIII Usage Reduced by 94% in Year 3 Compared to Baseline – 92% of Patients off Prophylaxis…
Preliminary fourth quarter highlights: Expected total fourth quarter revenue, excluding COVID–19 testing, increased 28% compared to the fourth quarter 2021, with Screening revenue of $401.8–$402.8 million and Precision Oncology revenue…